Management of acute myocardial infarction. Do we follow guidelines applied in practice?

Saudi Medical Journal

Volumn 24, Issue 11, 2003, Pages 1234-1237

  Khalil, Mohamed Z ^a   Abba, Abdullah A ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE;

ACUTE HEART INFARCTION; ARTICLE; AWARENESS; CLINICAL PRACTICE; COMMUNITY HOSPITAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; EVIDENCE BASED MEDICINE; FATALITY; FEMALE; FIBRINOLYTIC THERAPY; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATIENT CARE; PRACTICE GUIDELINE; QUALITY OF LIFE; SAUDI ARABIA; STATISTICAL ANALYSIS; SURVIVAL TIME;

ACUTE DISEASE; FEMALE; HUMANS; MALE; MEDICAL AUDIT; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES; SAUDI ARABIA; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0347503575     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 339: 861-867.
2. Second International Study of Infarction Survival Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-360.
3. Hennekens CH, Jonas MA, Buring JE. The benefits of aspirin in acute myocardial infarction. Arch Intern Med 1994; 154: 37-39.
4. Hennekens CH, O'Donnell CJ, Ridker PM, Marder VJ. Current issues concerning thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 1995; 25: 18S-22S.
5. Anderson HV, Willerson JT. Thrombolysis in acute myocardial infarction. N Engl J Med 1993; 329: 703-709.
6. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: A randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992; 339: 753-770.
7. Gruppo Italiano per lo Studio della Streptochinasi nell Infarcto Miocardico. GISSI-2. A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990; 336: 65-71.
8. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682.
9. Hartzler GO, Rutherford BD, McConahay DR, Johnson WL Jr, McCallister BD, Gura GM Jr et al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 1983; 106: 965-973.
10. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000; 283: 2941-2947.
11. Horie H, Takahashi M, Minai K, Izumi M, Takaoka A, Nozawa M et al. Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty. Circulation 1998; 98: 2377-2382.
12. Brodie BR, Grines CL, Ivanhoe R, Knopf W, Taylor G, O'Keefe J et al. Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction: Final results from the Primary Angioplasty Registry. Circulation 1994; 90: 156-162.
13. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986; 2: 57-66.
14. Viskin S, Kitzis I, Lev E, Zak Z, Heller K, Villa Y et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: From randomized trials to clinical practice. J Am Coll Cardiol 1995; 25: 1327-1332.
15. Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting enzyme inhibition. Lancet 1991; 337: 872-876.
16. Schulman SP, Weiss JL, Becker LC, Guerci AD, Shapiro EP, Chandra NC et al. Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction. Am J Cardiol 1995; 76: 764-770.
17. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE et al. For the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327: 669-677.
18. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-828.
19. Ambrosioni E, Borghi C, Magnani B, for the Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995; 332: 80-85.
20. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarcto Miocardico. Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: The GISSI-3 Trial. J Am Coll Cardiol 1996; 27: 337-344.
21. Jugdutt BI, Warnica JW. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications: Effect of timing, dosage, and infarct location. Circulation 1988; 78: 906-919.
22. Yusuf S, Collins R, MacMahon S, Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: An overview of the randomised trials. Lancet 1988; 1: 1088-1092.
23. ISIS-4 (Fourth International Study of Infarct Survival) collaborative group. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-685.
24. Gurwitz JH, Goldberg RJ, Chen Z, Gore JM. Beta-blocker therapy in acute myocardial infarction: evidence for under utilization in the elderly. Am J Med 1992; 93: 605-610.
25. McLaughlin TJ, Soumerai SB, Willison DJ, Gurwitz JH, Borbas C, Guadagnoli E, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction. Arch Intern Med 1996; 156: 799-805.
26. Mehta RJ, Ruane TJ, McCargar PA, Eagle KA, Stalhandske EJ. The treatment of elderly diabetic patients with acute myocardial infarction. Arc Intern Med 2000; 160: 1301-1306.
27. Alexander KP, Peterson ED, Granger CB, Casas AC, Van de Werf F, Armstrong PW et al. Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-Iib. J Am Coll Cardiol 1998; 32: 2023-2030.
28. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF et al. 1999 update: ACC/AHA Guidelines for the Management of Patients with Acute Myocardial Infarction: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practical Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999; 100: 1016.
29. Frishman WH, Skolnick AE, Miller KP. Secondary prevention post-infarction: The role of beta-adrenergic blockers, calcium channel blockers and aspirin. In: Gersh BJ, Rahimtoola S, editors. Acute Myocardial Infarction. New York (NY): Elsevier; 1991. p. 469.
30. Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients. Lancet 2000; 355: 1575-1581.
31. Mehta RH, Montoye CK, Gallogly M, Baker P, Blount A, Faul J et al. Improving Quality of Care for Acute Myocardial Infarction. The Guidelines Applied in Practice (GAP) Initiative. JAMA 2002; 287: 1269-1276.